Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke

Journal of Cerebral Blood Flow and Metabolism

Volumn 27, Issue 1, 2007, Pages 14-20

  Romanos, Eduardo ^a,b   Planas, Anna M ^a   Amaro, Sergio ^b   Chamorro, Ángel ^b  

^a INST D INVESTIGACIONS B   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Antioxidant; Cerebral ischemia; Thrombolysis

Indexed keywords

ALTEPLASE; TYROSINE; URIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN PERFUSION; CEREBROVASCULAR ACCIDENT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; FIBRINOLYTIC THERAPY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MONOTHERAPY; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NEUTROPHIL CHEMOTAXIS; NITRATION; NONHUMAN; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RAT; REPERFUSION; TIME; TREATMENT OUTCOME;

ANIMALS; BRAIN DAMAGE, CHRONIC; BRAIN EDEMA; CEREBROVASCULAR ACCIDENT; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; NEUTROPHIL INFILTRATION; NITRATES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; THROMBOEMBOLISM; TISSUE PLASMINOGEN ACTIVATOR; TYROSINE; URIC ACID;

EID: 33845804424     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jcbfm.9600312     Document Type: Article

References (32)

1. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P (2001) Antithrombotic and thrombolytic therapy for ischemic stroke. Chest 119:300S-20S
2. Becker BF (1993) Towards the physiological function of uric acid. Free Radic Biol Med 14:615-31
3. Bederson JB, Pitts LH, Tsuji M, Nishimura MC, Davis RL, Bartkowski H (1986) Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17:472-6
4. Busch E, Kruger K, Hossmann KA (1997) Improved model of thromboembolic stroke and rt-PA induced reperfusion in the rat. Brain Res 778:16-24
5. Chamorro A, Obach V, Cervera A, Revilla M, Deulofeu R, Aponte JH (2002) Prognostic significance of uric acid serum concentration in patients with acute ischemic stroke. Stroke 33:1048-52
6. Chamorro A, Planas AM (2004) Yin and yang of uric acid in patients with stroke. Stroke 35:e11-2
7. Chamorro A, Planas AM, Muner DS, Deulofeu R (2004) Uric acid administration for neuroprotection in patients with acute brain ischemia. Med Hypotheses 62:173-6
8. Cheng YD, Al-Khoury L, Zivin JA (2004) Neuroprotection for ischemic stroke: two decades of success and failure. NeuroReport 1:36-45
9. Fisher M, for the Stroke Therapy Academic Industry Roundtable (2003) Recommendations for advancing development of acute stroke therapies stroke therapy academic industry roundtable 3. Stroke 34:1539-46
10. Green AR, Ashwood T (2005) Free radical trapping asa therapeutic approach to neuroprotection in stroke: experimental and clinical studies with NXY-059 and free radical scavengers. Curr Drug Targets CNS Neurol Disord 4:109-18
11. Gursoy-Ozdemir Y, Can A, Dalkara T (2004) Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35:1449-53
12. Justicia C, Martín A, Rojas S, Gironella M, Cervera A, Panés J, Chamorro A, Planas AM (2006) Anti-VCAM-1 antibodies did not protect against ischemic damage neither in rats nor in mice. J Cereb Blood Flow Metab 26:421-32
13. Justicia C, Panés J, Solé S, Cervera A, Deulofeu R, Chamorro A, Planas AM (2003) Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 23:1430-40
14. Justicia C, Pérez-Asensio FJ, Burguete MC, Salom JB, Planas AM (2001) Administration of transforming growth factor-α reduces infarct volume after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 21:1097-104
15. Korninger C, Collen D (1981) Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb Haemost 46:561-5
16. Lapchak PA, Zivin JA (2003) Ebselen, a seleno-organic antioxidant, is neuroprotective after embolic strokes in rabbits: synergism with low-dosetissue plasminogen activator. Stroke 34:2013-8
17. Love S (1999) Oxidative stress in brain ischemia. Brain Pathol 9:119-31
18. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581-7
19. Niessen F, Hilger T, Hoehn M, Hossman KA (2003) Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke. Stroke 34:2019-24
20. Overgaard K, Sereghy T, Frellsen M, Pedersen H, Høyer S, Boysen G (1993) Composition of emboli influences the efficacy of thrombolysis with rt-PA in a rat stroke model. Fibrinolysis 7:141-8
21. Overgaard K, Sereghy T, Pedersen H, Boysen G (1994) Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model. J Cereb Blood Flow Metab 14:472-7
22. Perez-Asensio FJ, Hurtado O, Burguete MC, Moro MA, Salom JB, Lizasoain I, Torregrosa G, Leza JC, Alborch E, Castillo J, Knowles RG, Lorenzo P (2005) Inhibition of iNOS activity by 1400 W decreases glutamate release and ameliorates stroke outcome after experimental ischemia. Neurobiol Dis 18:375-84
23. Piriyawat P, Labiche LA, Burgin WS, Aronowski JA, Grotta JC (2003) Pilot dose-escalation study of caffeine plus ethanol (caffeinol) in acute ischemic stroke. Stroke 34:1242-5
24. Radi R (2004) Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA 101:4003-8
25. Saver JL, Kidwell C, Eckstein M, Starkman S (2004) FAST-MAG Pilot Trial Investigators. Prehospital neuroprotective therapy for acute stroke: results of the Field Administration of Stroke Therapy-Magnesium (FAST-MAG) pilot trial. Stroke 35:106-8
26. Scott GS, Cuzzocrea S, Genovese T, Koprowski H, Hooper DC (2005) Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci USA 102:3483-8
27. Squadrito GL, Cueto R, Splenser AE, Valavanidis A, Zhang H, Uppu RM, Pryor WA (2000) Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid. Arch Biochem Biophys 376:333-7
28. Suzuki M, Sasamata M, Miyata K (2003) Neuroprotective effects of YM872 coadministered with t-PA in a rat embolic stroke model. Brain Res 959:169-72
29. Waring WS, Webb DJ, Maxwell RJ (2001) Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers. J Cardiovasc Pharmacol 38:365-71
30. Watanabe T, Yuki S, Egawa M, Nishi H (1994) Protective effects of MCI-186 on cerebral ischemia: possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268:1597-604
31. Weir CJ, Muir SW, Walters MR, Lees KR (2003) Serum urate asan independent predictor of poor outcome and future vascular events after acute stroke. Stroke 34:1951-6
32. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP (1998) Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 53:613-25